Orchid Pharma Appoints New Whole-Time Director and Sets 33rd AGM Date
Orchid Pharma Ltd 路 Outcome 路 04 Sept 2026, 1:41 am
Orchid Pharma Appoints New Whole-Time Director and Sets 33rd AGM Date Orchid Pharma's board approved Mr. Arjun Dhanuka's elevation to Whole-Time Director for a five-year term effective 3rd Sep'26, transitioning him from a non-executive role. The board also appointed M/s. J Karthikeyan & Associates as Cost Auditor for FY27, pending shareholder ratification. Furthermore, the company scheduled its 33rd Annual General Meeting for 29th Sep'26. The cut-off date for AGM notice eligibility is set for 4th Sep'26, with the e-voting eligibility cut-off on 22nd Sep'26.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
